A. Widmark et al., ESTRAMUSTINE POTENTIATES THE EFFECTS OF IRRADIATION ON THE DUNNING (R3327) RAT PROSTATIC ADENOCARCINOMA, The Prostate, 24(2), 1994, pp. 79-83
The present study was designed to determine if estramustine phosphate
(EMP) could potentiate the effects of irradiation on the Dunning (R332
7) prostatic adenocarcinoma in rats. Two groups of male Copenhagen x F
isher F1 rats carrying bilateral tumors in the flank were used. Irradi
ation was given with a linear accelerator 6 MV, in a dose of 6 Gy/day
for 4 days to the tumor on one side while the tumor on the other side
served as control. EMP (360 mu g/24 hours) was administered with osmot
ic pumps to one group of rats for 2 weeks, starting 1 week before irra
diation. Tumor growth was calculated by measuring tumor volume, and tu
mor blood flow was measured 8 weeks after treatment. Irradiation alone
effectively delayed tumor growth and EMP enhanced these effects. Tumo
r blood flow was stimulated by EMP treatment irrespective of radiother
apy. Volume density of tumor epithelium was effectively decreased by i
rradiation but no significant effects could be seen after EMP. In conc
lusion, the present study shows that EMP potentiates irradiation on ra
t prostatic adenocarcinoma, and further evaluation of this therapeutic
approach in the clinical treatment of prostatic carcinoma is thus jus
tified. (C) 1994 Wiley-Liss, Inc.